Several components in marijuana are responsible for combatting inflammation
While inflammation is an essential part of the body’s immune response, when it becomes chronic, it can do more harm than good. Chronic inflammation occurs when the immune system mistakenly attacks healthy cells in your body. In many cases, chronic inflammation can lead to a number of diseases and conditions, including rheumatoid arthritis and even some types of cancer. A recent study conducted by Gb Sciences looks at how cannabis terpenes are able to reduce inflammation.
Inspired by plants, Gb Sciences is a leading biopharmaceutical research and drug development firm. The company wanted to delve deeper into the topic of cannabis and inflammation and therefore published a study that demonstrates the great potential that both terpenes and cannabinoids have to reduce this condition.
The research used different co-cultured human primary immune cells as a model in order to analyze the ability of selected components of marijuana to say goodbye to inflammation. This is considered the first demonstration of the anti-inflammatory potential of potent minor cannabinoids and terpenes derived from marijuana, says Dr. Andrea Small-Howard, president, CSO and director of Gb Sciences.
She added, “The identification of cell type-specific immune modulating effects by different individual cannabinoids and terpenes was an important first step in designing our novel anti-inflammatory therapies.” Extra results from a second study on the anti-inflammatory effects of proprietary mixtures of these ingredients are expected to be published soon.
The study confirms that different marijuana compounds with inflammatory properties can be extremely helpful for people to mitigate inflammation linked to a wide variety of serious disorders. The authors make it clear that these compounds are even more favorable than the current drugs that lead the anti-inflammatory market and that, unfortunately, generate many side effects.